Maria Aigner

634 total citations
14 papers, 303 citations indexed

About

Maria Aigner is a scholar working on Infectious Diseases, Epidemiology and Cell Biology. According to data from OpenAlex, Maria Aigner has authored 14 papers receiving a total of 303 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Infectious Diseases, 11 papers in Epidemiology and 3 papers in Cell Biology. Recurrent topics in Maria Aigner's work include Antifungal resistance and susceptibility (14 papers), Fungal Infections and Studies (10 papers) and Plant Pathogens and Fungal Diseases (3 papers). Maria Aigner is often cited by papers focused on Antifungal resistance and susceptibility (14 papers), Fungal Infections and Studies (10 papers) and Plant Pathogens and Fungal Diseases (3 papers). Maria Aigner collaborates with scholars based in Austria. Maria Aigner's co-authors include Cornelia Lass‐Flörl, David Nachbaur, Johannes Clausen, Jutta Auberger, Günther Gastl, Astrid Mayr, Michaela Lackner, Stephan Eschertzhuber, Martin Gschwentner and Ingo Lorenz and has published in prestigious journals such as Journal of Clinical Microbiology, Antimicrobial Agents and Chemotherapy and Journal of Antimicrobial Chemotherapy.

In The Last Decade

Maria Aigner

14 papers receiving 298 citations

Peers

Maria Aigner
Mark Wissel United States
Dorien Ruegebrink Netherlands
Samuel Lee South Korea
Ga‐Lai M. Chong Netherlands
Marie Kirwan United Kingdom
Maria Aigner
Citations per year, relative to Maria Aigner Maria Aigner (= 1×) peers Martina Tošková

Countries citing papers authored by Maria Aigner

Since Specialization
Citations

This map shows the geographic impact of Maria Aigner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Maria Aigner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Maria Aigner more than expected).

Fields of papers citing papers by Maria Aigner

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Maria Aigner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Maria Aigner. The network helps show where Maria Aigner may publish in the future.

Co-authorship network of co-authors of Maria Aigner

This figure shows the co-authorship network connecting the top 25 collaborators of Maria Aigner. A scholar is included among the top collaborators of Maria Aigner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Maria Aigner. Maria Aigner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Oberacher, Herbert, Ingo Lorenz, Peter Schellongowski, et al.. (2021). Penetration of echinocandins into wound secretion of critically ill patients. Infection. 49(4). 747–755. 3 indexed citations
2.
Oberacher, Herbert, Andrea Griesmacher, Cornelia Lass‐Flörl, et al.. (2021). Pharmacokinetics and Antifungal Activity of Echinocandins in Ascites Fluid of Critically Ill Patients. Antimicrobial Agents and Chemotherapy. 65(7). e0256520–e0256520. 9 indexed citations
3.
Lass‐Flörl, Cornelia, Robert Krause, Birgit Willinger, et al.. (2020). Clinical Usefulness of Susceptibility Breakpoints for Yeasts in the Treatment of Candidemia: A Noninterventional Study. Journal of Fungi. 6(2). 76–76. 4 indexed citations
4.
Binder, Ulrike, et al.. (2019). Minimal Inhibitory Concentration (MIC)-Phenomena in Candida albicans and Their Impact on the Diagnosis of Antifungal Resistance. Journal of Fungi. 5(3). 83–83. 12 indexed citations
5.
Aigner, Maria, et al.. (2019). Candida in the Respiratory Tract Potentially Triggers Galactomannan Positivity in Nonhematological Patients. Antimicrobial Agents and Chemotherapy. 63(6). 17 indexed citations
6.
Maurer, Elisabeth, Maria Aigner, Cornelia Lass‐Flörl, & Ulrike Binder. (2019). Hypoxia Decreases Diagnostic Biomarkers for Aspergillosis In Vitro. Journal of Fungi. 5(3). 61–61. 2 indexed citations
7.
Lass‐Flörl, Cornelia, Astrid Mayr, Maria Aigner, Michaela Lackner, & Dorothea Orth‐Höller. (2018). A nationwide passive surveillance on fungal infections shows a low burden of azole resistance in molds and yeasts in Tyrol, Austria. Infection. 46(5). 701–704. 12 indexed citations
8.
Lass‐Flörl, Cornelia, Maria Aigner, David Nachbaur, et al.. (2017). Diagnosing filamentous fungal infections in immunocompromised patients applying computed tomography-guided percutaneous lung biopsies: a 12-year experience. Infection. 45(6). 867–875. 20 indexed citations
9.
Aigner, Maria, et al.. (2017). Etest and Sensititre YeastOne Susceptibility Testing of Echinocandins against Candida Species from a Single Center in Austria. Antimicrobial Agents and Chemotherapy. 61(8). 18 indexed citations
10.
Aigner, Maria, et al.. (2015). Isavuconazole: an orphan drug for treating invasive candidiasis. Expert Opinion on Orphan Drugs. 4(3). 333–342. 2 indexed citations
12.
Lass‐Flörl, Cornelia, Maria Aigner, Katharina Grif, et al.. (2012). Utility of PCR in Diagnosis of Invasive Fungal Infections: Real-Life Data from a Multicenter Study. Journal of Clinical Microbiology. 51(3). 863–868. 53 indexed citations
13.
Mayr, Astrid, Maria Aigner, & Cornelia Lass‐Flörl. (2011). Anidulafungin for the treatment of invasive candidiasis. Clinical Microbiology and Infection. 17. 1–12. 16 indexed citations
14.
Mayr, Astrid, Maria Aigner, & Cornelia Lass‐Flörl. (2011). Caspofungin: when and how? The microbiologist’s view. Mycoses. 55(1). 27–35. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026